Page last updated: 2024-10-16

9-xylosyladenine and Leukemia, Erythroblastic, Acute

9-xylosyladenine has been researched along with Leukemia, Erythroblastic, Acute in 1 studies

9-xylosyladenine: RN given refers to cpd with unspecified isomeric designation; structure in first source

Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

Research Excerpts

ExcerptRelevanceReference
"Friend virus-transformed mouse erythroleukemia (MEL) cells can be induced to undergo erythroid differentiation by a variety of compounds, including dimethyl sulfoxide (DMSO) and the adenosine analog xylosyladenine."1.27Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells. ( Kufe, DW; Shafman, TD; Sherman, ML, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sherman, ML1
Shafman, TD1
Kufe, DW1

Other Studies

1 other study available for 9-xylosyladenine and Leukemia, Erythroblastic, Acute

ArticleYear
Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.
    Journal of cellular physiology, 1988, Volume: 134, Issue:3

    Topics: Adenosine; Animals; Cell Differentiation; Cell Division; Cell Survival; Cyclic AMP; Dimethyl Sulfoxi

1988